Connections between the lacrimal gland and sensory trigeminal ...
In all monkeys a solidified piece of wheat germ agglutinin/horsereadish peroxidase (WGA/HRP) (Sigma) in Willospon (Willpharma), prepared by soaking a
small ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571477/...
|
...
|
pone.0000654 1..7
Sharp & Dome, and Will-Pharma. The study's sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920553/pdf/pone...
|
Clinical Evidence Concise - June 1, 2005 - American Family Physician
1 Jun 2005 ... Procter & Gamble Pharmaceuticals, Rotta Research, Sanofi, Servier, SmithKline Beecham, Teva, Therabel, Tosse, Byk, UCB, and Will Pharma. ...
http://www.aafp.org/afp/20050601/bmj.html...
|
Connections between the lacrimal gland and sensory trigeminal ...
in Willospon (Willpharma), prepared by soaking a small piece of Willospon (1.0 mm) in a 10% WGA/HRP phos- phate buffer solution, was implanted by surgery in
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571477/pdf/joa_...
|
GSK CR Report 2007 - Background information - Access to medicines ...
healthcare budgets will pharma companies expect to take in return for waiving IP protection for their drugs?” “NGO rhetoric excludes a discussion on how to ...
http://www.gsk.com/responsibility/cr-review-2007/downloads/G...
|
Detection of diazepam in urine, hair and preserved oral fluid ...
In this study, we describe the detection of low amounts of diazepam in Myolastan (Sanofi-Synthelabo S.A., Brussels, Belgium) and Epsipam (Will-Pharma, ...
http://www.ncbi.nlm.nih.gov/pubmed/17468852...
|
Withdrawal of Fall-Risk-Increasing Drugs in Older Persons: Conclusion
... van der Cammen received funding for this study from the Erasmus University Medical Center and from grants from Merck Sharp & Dome and Will-Pharma. ...
http://www.medscape.com/viewarticle/558037_5...
|
Risk of falls after withdrawal of fall-risk-increasing drugs: a ...
Competing interests: This study was funded by Erasmus University MC, and by funds from Merck Sharp & Dohme, and Will-Pharma. The study's sponsors had no ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000574/...
|
Research and Markets: Key Development Features of the Chinese ...
22 Nov 2009 ... 4.4 How will pharma outsourcing develop in China in 2010? 4.5 How will each service sector of Chinese pharma outsourcing industry move in ...
http://biz.yahoo.com/bw/091122/20091122005004.html?.v=1...
|
